Cerebrolysin, explained simply

Cerebrolysin is administered as an IM or IV injection of a porcine brain-derived peptide solution. ^{10Source 10Cerebrolysin Treatment HandbookEVER Neuro Pharma GmbH · 202311Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 2024} Local reactions (pain, redness, swelling) occur in 5-15% of patients, particularly with IM administration. Reactions are typically mild to moderate, localized to the injection area, and resolve within 24-48 hours. More common with higher volumes (>10 ml) or faster infusion rates. Incidence increases with repeated injections at the same site.

What to do Rotate injection sites for IM administration to different locations (deltoid, gluteal). For IV administration, use large-bore IV catheter in forearm or antecubital fossa to minimize local irritation. Apply warm compress (not ice) to injection site if soreness develops. Topical analgesic cream may help. Reactions typically resolve without intervention within 24-48 hours.

Headache is reported in 10-15% of patients treated with Cerebrolysin, usually mild to moderate. It typically occurs during or within 1-2 hours of the IV infusion, most often with standard (10-30 ml) or higher doses. The cause is unclear but may relate to changes in blood flow or to nerve-growth peptides (peptides that support nerve cells) quickly crossing into the brain. It usually responds to standard pain relievers and clears within 2-4 hours.

What to do Usually transient and self-resolving within 2-4 hours. Acetaminophen (500-1000 mg) or ibuprofen (400 mg) may be administered. Reducing the IV infusion rate (give over 30-60 minutes rather than faster) significantly reduces incidence. Ensure adequate hydration before and during infusion. Headache on subsequent injections often decreases or disappears.

Dizziness or mild vertigo is reported in 3-8% of Cerebrolysin patients, typically occurring within 30 minutes of IV administration. Episodes are usually brief (15-60 minutes) and self-limited. Related to transient hemodynamic effects or rapid CNS peptide influx across blood-brain barrier. More common with rapid infusion rates or doses >20 ml. ^{10Source 10Cerebrolysin Treatment HandbookEVER Neuro Pharma GmbH · 202311Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 202424Source 24Cerebrolysin: a review of its use in dementiaPlosker GL, Gauthier S · 2009} Vertigo (sensation of room spinning) is less common than simple dizziness.

What to do Rest in supine or semi-recumbent position until symptoms resolve. Avoid driving or operating machinery for 2-4 hours after infusion. Slow the IV infusion rate—administering over 30-60 minutes rather than rapid injection markedly reduces dizziness incidence. Ensure adequate hydration and avoid rapid position changes. Symptoms typically subside without specific treatment within 15-60 minutes.

Nausea occurs in approximately 3-5% of Cerebrolysin patients, usually mild and transient. May be accompanied by mild stomach discomfort or mild appetite suppression. ^{11Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 2024} More common with IM administration than IV. Usually occurs within 30 minutes of injection and resolves within 1-2 hours. Mechanism likely relates to the peptide mixture stimulating GI sensory neurons or mild hemodynamic effects.

What to do Administer with the patient in a comfortable supine or semi-recumbent position. Ensure adequate hydration before and after injection. Slow IV infusion rate reduces incidence significantly. Small frequent meals rather than large meals during treatment course. Ginger tea or peppermint may help symptomatically. Symptoms are usually brief and self-limiting without specific treatment; rarely requires antiemetic medications.

Agitation or restlessness occurs in approximately 2-4% of patients, more commonly at doses >20 ml or with IV administration. Characterized by nervousness, inability to sit still, or mild irritability lasting 30 minutes to 2 hours after injection. May relate to cholinergic stimulation by neuropeptide fragments or enhanced neuronal activation. More common when Cerebrolysin is given late in the day. ^{10Source 10Cerebrolysin Treatment HandbookEVER Neuro Pharma GmbH · 202311Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 2024}

What to do More common at higher doses—consider dose reduction if significant. Administer earlier in the morning (before 2 PM) to avoid sleep disruption at night. Patients can engage in calm, low-stimulation activities during treatment period. If agitation is bothersome, healthcare provider may recommend dose reduction or slower infusion. Symptoms typically resolve without specific intervention within 1-4 hours.

Fever occurs in approximately 1-3% of Cerebrolysin patients, typically low-grade (38-38.5°C / 100.4-101.3°F) and transient. Usually occurs 2-4 hours after injection and resolves spontaneously within 4-8 hours. Mechanism likely represents immune response to foreign porcine proteins or pyrogenic contaminants. ^{10Source 10Cerebrolysin Treatment HandbookEVER Neuro Pharma GmbH · 202311Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 2024} Higher incidence with IM administration and higher doses. Fever on repeated injections often decreases in frequency and severity.

What to do Monitor body temperature during treatment course. Low-grade fever (<38.5°C) typically requires no specific treatment and resolves without intervention. Acetaminophen (500-1000 mg) or ibuprofen (400 mg) may reduce discomfort if desired. Ensure adequate hydration. If fever is persistent (>8 hours), high-grade (>39°C), or accompanied by other systemic (affecting the whole body) symptoms, evaluate for alternative causes (infection, etc.). Fever on repeat injections usually decreases or disappears.

Allergic reactions to Cerebrolysin are rare (<1%) but possible because it is made from pig protein. ^{11Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 202422Source 22Life-Threatening Anaphylaxis due to Cerebrolysin®Trimmel H, Tauber W, Zikeli M · 2024} Reactions range from mild (local rash, mild hives) to severe (deep swelling of the face or throat, tightening of the airways). Risk is highest in people with known pork allergies or a strong allergic tendency. Most reactions occur within 15-30 minutes of injection. Delayed reactions (24-48 hours) are rare but possible if you become sensitized and are exposed again.

What to do Stop immediately if any sign of allergy appears (rash, hives, facial swelling, deep tissue swelling under the skin, difficulty breathing, wheezing). Have emergency medications and epinephrine on hand during Cerebrolysin injections, especially if the patient has had allergies before. Mild local reactions may respond to an antihistamine (diphenhydramine 25-50 mg). People with known pork allergies should avoid Cerebrolysin or have desensitization testing first.

Severe allergic reactions are rare but life-threatening. They include deep swelling of the face or throat, severe tightening of the airways, and collapse of blood pressure and circulation. The risk is higher in people allergic to products made from pigs ^{11Source 11Cerebrolysin (Церебролизин) solution for injection 215.2 mg/mL — approved instruction for medical use, Russian FederationEVER Neuro Pharma GmbH (registered product information) · 202422Source 22Life-Threatening Anaphylaxis due to Cerebrolysin®Trimmel H, Tauber W, Zikeli M · 2024}.

What to do Discontinue immediately. Administer epinephrine IM (0.3-0.5 mg of 1:1000 solution). Provide airway support and IV antihistamines. Transfer to emergency care. Have emergency medications and resuscitation equipment available before administration.